Sublimity Therapeutics

Developer of drugs for gastrointestinal and immunological diseases

placeDublin, Leinster, Ireland calendar_todayFounded 2003 groups50 employees language sublimitytherapeutics.com

Registered entities

Innovation

9 patent families (7 granted) — focus: Human necessities; filing pace slowing. Cited 1,286 times.

YearFilings
20172
20193
20204
20213
20223
20232
20245

Investor mix

6 investors on record; lead investors include Orbimed, Longitude Capital.

Investor typeCountShare
Venture capital117%
Private equity350%
Accelerator & incubator117%
Other / undisclosed117%
Coming soon